RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0034-1396327
Cilioretinal Artery Occlusion
Zilioretinale ArteriolenverschlüssePublikationsverlauf
Publikationsdatum:
22. April 2015 (online)
Abstract
Background: The aim of this study was to evaluate characteristic findings and functional outcome of this rare type of retinal vascular occlusion in a large patient series. Patients and Methods: A retrospective chart review of all patients with a cilioretinal artery obstruction (CAO) seen at the University Eye Clinic Mainz (Germany) over a ten-year period between 1/1999 and 12/2008 was undertaken. The mean follow-up amounted to 42 months. Results: Thirty-three eyes were diagnosed with CAO. Three distinct groups were differentiated: (i) isolated CAO in 20/33 eyes; visual outcome achieving 20/50 in 17/20 eyes; (ii) CAO combined with central retinal vein occlusion in 9/33 eyes; visual outcome achieving 20/50 in 5/9 eyes; (iii) CAO combined with anterior ischaemic optic neuropathy in 4/33 eyes; associated with giant cell arteriitis in 4/4 eyes; visual outcome achieving 20/160 in 1/4 eyes. Conclusions: The visual prognosis of CAO is significantly better than for other types of retinal artery occlusions, with the exception of cases associated with giant cell arteriitis.
Zusammenfassung
Hintergrund: Auswertung charakteristischer Befunde und Funktionsergebnisse dieses seltenen Verschlusstyps eines arteriellen Netzhautgefäßes in einem großen Patientenkollektiv. Patienten und Methoden: Retrospektive Analyse der Krankenblattunterlagen aller Patienten mit zilioretinalem Arteriolenverschluss, die an der Universitäts-Augenklinik Mainz (Deutschland) in der Dekade 1.1999 bis 12.2008 diagnostiziert wurden. Median der Nachbeobachtung waren 42 Monate. Ergebnisse: Bei 33 Augen mit einem zilioretinalen Arteriolenverschluss wurden 3 Gruppen unterschieden: (1) isolierter zilioretinaler Verschluss in 20/33 Augen mit einer Endsehschärfe von mindestens 0,4 in 17/20 Augen; (2) zilioretinaler Verschluss kombiniert mit Zentralvenenverschluss in 9/33 Augen mit einer Endsehschärfe von mindestens 0,4 in 5/9 Augen; (3) zilioretinaler Verschluss kombiniert mit anteriorer ischämischer Optikusneuropathie in 4/33 Augen, assoziiert mit Riesenzellarteriitis in 4/4 Augen und einer Endsehschärfe von mindestens 0,12 in 1/4 Augen. Schlussfolgerung: Die Visusprognose von zilioretinalen arteriellen Verschlüssen ist signifikant besser als bei anderen Gefäßverschlüssen der Netzhaut, ausgenommen sind Fälle mit assoziierter Riesenzellenarteriitis.
-
References
- 1 Justice jr. J, Lehmann RP. Cilioretinal arteries. A study based on review of stereo fundus photographs and fluorescein angiographic findings. Arch Ophthalmol 1976; 94: 1355-1358
- 2 Brown GC, Shields JA. Cilioretinal arteries and retinal arterial occlusion. Arch Ophthalmol 1979; 97: 84-92
- 3 Hayreh SS. The cilioretinal arteries. Br J Ophthalmol 1963; 47: 71-89
- 4 Hayreh SS, Podhajsky PA, Zimmerman MB. Branch retinal artery occlusion natural history of visual outcome. Ophthalmolgy 2009; 116: 1188.e1-4-1194.e1-4
- 5 Rumelt S, Brown GC. Update on treatment of retinal arterial occlusions. Curr Opin Ophthalmol 2003; 14: 139-141
- 6 Fry RA, Ring P. Cilioretinal artery occlusion associated with SLE and the administration of a sub-Tenons block. Clin Experiment Ophthalmol 2008; 36: 493-494
- 7 Ghandi JS, Ziahosseini K. Cilioretinal perfusion in concurrent cilioretinal and central retinal vein occlusions. Can J Ophthalmol 2008; 43: 121-122
- 8 Krauss F. Embolism of the cilioretinal artery. Ophthalmol Rec 1907; 16: 196-202
- 9 Kumaran N, Liyanage S, Angunawela R et al. Cilioretinal artery occlusion secondary to an evolving retinal vein occlusion. Can J Ophthalmol 2008; 43: 127
- 10 Levitt JM. Occlusion of the cilioretinal artery. Arch Ophthalmol 1948; 40: 152-156
- 11 Zentmayer W. Embolism of a cilioretinal artery. Ophthalmol Rec 1906; 15: 613
- 12 Hansen LL, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 1989; 73: 895-899
- 13 Kollarits CR, Lubow M, Hissong SL. Retinal strokes. J Am Med Assoc 1972; 222: 1273-1275
- 14 Mitchell P, Wang JJ, Smith W. Risk factors and significance of finding asymptomatic retinal emboli. Clin Exp Ophthalmol 2000; 28: 13-17
- 15 Sharma S, Brown GC, Pater JL et al. Accuracy of visible retinal emboli for the detection of cardioembolic lesions requiring anticoagulation or cardiac surgery. Retinal Emboli of Cardiac Origin Study Group. Br J Ophthalmol 1998; 82: 655-658
- 16 Sharma S, Brown GC, Pater JL et al. Does a visible retinal embolus increase the likelihood of hemodynamically significant carotid artery stenosis in patients with acute retinal arterial occlusion?. Arch Ophthalmol 1998; 116: 1602-1606
- 17 Schmidt D. A fluorescein angiographic study of branch retinal artery occlusion (BRAO) – the retrograde filling of occluded vessels. Eur J Med Res 1999; 4: 491-506
- 18 Brazitikos PD, Pournaras CJ, Othenin-Girard P et al. Pathogentic mechanisms in combined cilioretinal artery and retinal vein occlusions: a reappraisal. Int Ophthalmol 1993; 17: 235-242
- 19 Hayreh SS, Fraterrigo L, Jonas J. Central retinal vein occlusion associated with cilioretinal artery occlusion. Retina 2008; 28: 581-594
- 20 Henkind P, Charles NC, Pearson J. Histopathology of ischemic optic neuropathy. Am J Ophthalmol 1970; 69: 78-90
- 21 Mueller AJ, Neubauer AS, Schaller U et al. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. Arch Ophthalmol 2003; 121: 1377-1381
- 22 Savino PJ, Glaser JS, Cassady J. Retinal stroke. Is the patient at risk?. Arch Ophthalmol 1977; 95: 1185-1189
- 23 Bruno A, Jones WL, Austin JK et al. Vascular outcome in men with asymptomatic retinal cholesterol emboli. A cohort study. Ann Intern Med 1995; 122: 249-253